Valeant Pharmaceuticals International has named Joseph C. Papa as its future chairman and chief executive officer. He is expected to join the company by early May. Papa will succeed J. Michael Pearson. Valeant's board had been searching for the right candidate to take over the chief executive role since March, ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.